Syncona Limited

Research Syncona Limited (SYNC) on Bullrun: market cap GBX 65.70B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is GBX 65.70B.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2026USD 55.89M-USD 8.81MUSD 23.33Mn/a-0.01USD 1.92Mn/aUSD 1.04B
FY2025-USD 68.31M-USD 143.16MUSD 43.92Mn/a-0.22USD 1.11Mn/aUSD 1.05B
FY2024USD 63.75MUSD 3.79MUSD 20.47Mn/a0.01USD 261.00Kn/aUSD 1.24B
FY2023-USD 23.98M-USD 56.02M-USD 265.00Kn/a-0.08USD 11.00Kn/aUSD 1.25B
FY2022USD 33.70MUSD 8.84MUSD 262.00Kn/a0.01USD 276.00Kn/aUSD 1.31B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-10GBX 65.70Bn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 GBX.

About Syncona Limited

Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe.

Related stock research

Other Financial Services stocks

Frequently asked questions

What is Syncona Limited's market cap?

Syncona Limited's market capitalization is GBX 65.70B.

What does Syncona Limited do?

Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe.